Filing Details
IONIS PHARMACEUTICALS INC (NASDAQ:IONS) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event.
8k filedNASDAQ:IONS
IONIS PHARMACEUTICALS INC (IONS) Reports Material Event to SEC
Filing Details IONIS PHARMACEUTICALS INC (NASDAQ:IONS) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event. Market Context…
Market Context
IONIS PHARMACEUTICALS INC's stock currently trades at $64.27 with a market capitalization of $12.6B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for IONIS PHARMACEUTICALS INC's stock.
All SEC filings for IONIS PHARMACEUTICALS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IONS Stock Page
Frequently Asked Questions
Where can I read IONS's SEC filings?
Browse all filings on our IONS SEC filings page.
What types of SEC filings does IONIS PHARMACEUTICALS INC file?
Public companies like IONIS PHARMACEUTICALS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.